Gene Therapy

FDA Approves Otarmeni: First Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program

FDA · Genetic Hearing Loss · 3 min

FDA Approves Regeneron's Otarmeni: First Gene Therapy for Genetic Hearing Loss Shows 80% Success Rate

FDA · Genetic Hearing Loss · 4 min

INTERPHEX 2026: Avantor, BioLife Solutions, AES Highlights

biotech · 4 min

BioMed Israel: What to Expect at the 2026 Biotech Forum

general · 8 min

ASGCT 2026: Gene Therapy Advances from Circio, Encoded & More

general · 4 min

ASGCT 2026: Gene Therapy Manufacturing Advances to Watch

manufacturing · 4 min

Medera's AAV-SERCA2a Gene Therapy Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Cardiomyopathy

FDA · 2 min

MeiraGTx to Present 3-Year AAV-hAQP1 Gene Therapy Data for Radiation-Induced Xerostomia Treatment

2 min

FDA Approves LumaGen Gene Therapy for Inherited Retinal Disease

FDA · Inherited Retinal Disease · 8 min

FDA Approves Kresladi: First Gene Therapy for Rare Immune Disorder LAD-I Marks Medical Breakthrough

FDA · Rare genetic immunodeficiency disorders · 3 min

FDA Approval Gene Therapies: Market Analysis Post-Hemophilia Innovations

FDA · Hemophilia A · 7 min